<DOC>
	<DOCNO>NCT00430365</DOCNO>
	<brief_summary>Maintenance treatment myeloma .</brief_summary>
	<brief_title>Maintenance Therapy Using Lenalidomide Myeloma</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Lenalidomide</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<criteria>No sign progression transplant Effective contraception necessary ( oral contraception female barrier method contraception sexually active male ) No active severe infection Satisfactory restoration haematological parameter define : PN &gt; 1,000/mm3 Platelets &gt; 75,000/mm3 Bilirubin &lt; 35 umol/l GOT/GPT/PAL &lt; 3N Creatinine &lt; 160 umol/l .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Myeloma</keyword>
	<keyword>Revlimid</keyword>
	<keyword>Maintenance therapy</keyword>
	<keyword>Autologous Stem Cell Transplantation</keyword>
</DOC>